XAIR
XAIR clinical trials: Beyond Air, Inc.
Every trial on ClinicalTrials.gov where Beyond Air, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 10
- Trials linked
- 10
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
XAIR on the catalyst calendar · XAIR registry changes
- Primary completion Aug 31, 2025ActualPhase 1NCT05351502A Study to Assess the Safety and Efficacy of UNO - Ultra High Concentration Nitric Oxide Injection in Combination With PD-1 Inhibitors...Beyond Air Inc. · CancerTerminatedXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 28, 2022ActualNo phase registeredNCT04685720A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF PatientsBeyond Air Inc. · Non-Tuberculous Mycobacterial PneumoniaCompletedXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 7, 2022ActualNo phase registeredNCT04606407Inhaled NO for the Treatment of Viral Pneumonia in AdultsBeyond Air Inc. · Viral PneumoniaCompletedXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2020ActualNo phase registeredNCT04397692Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)Beyond Air Inc. · Corona Virus InfectionTerminatedXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 15, 2020Sponsor estimatePhase 2NCT04456088Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)Beyond Air Inc. · COVID-19WithdrawnXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2, 2020ActualPhase 2NCT04060979Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With BronchiolitisBeyond Air Inc. · Bronchiolitis AcuteCompletedXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 1, 2018ActualPhase 2NCT03208764Inhaled Nitric Oxide for Patients With MABSCBeyond Air Inc. · Mycobacterium Abscessus InfectionCompletedXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 28, 2018ActualPhase 3NCT03053388Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With BronchiolitisBeyond Air Inc. · BronchiolitisCompletedXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2015ActualPhase 1/Phase 2NCT01958944Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic FibrosisBeyond Air Inc. · Cystic FibrosisCompletedXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2016ActualPhase 1/Phase 2NCT01768884Evaluation of the Safety and Tolerability of Nitric Oxide (NO) Via Inhalation to Subjects With BronchiolitisBeyond Air Inc. · BronchiolitisCompletedXAIRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 10 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner